Europe In-Vitro Fertilization (IVF) Market Introduction and Overview
According to SPER Market Research, the Europe In-Vitro Fertilization (IVF) Market is estimated to reach USD 7.28 Billion by 2033 with a CAGR of 5.6%.
The report includes an in-depth analysis of the Europe In-Vitro Fertilization (IVF) Market, including market size and trends, product mix, applications, and supplier analysis. Throughout the clinical sector, in vitro fertilisation is one kind of assisted reproductive technology-based fertility treatment. Since the likelihood of conceiving decreases with age, delayed conception in women is a significant element driving the IVF industry. The age range of 35–39 years old has a higher success rate when using the IVF process to get pregnant.
Market Opportunities and Challenges
The European IVF market is expected to be driven by factors such as growing support for the expansion of infertility clinics and services throughout Europe, a growing emphasis on fertility protection initiatives among market participants, and education aimed at strengthening the network for exchanging best practices and concise information on infertility and fertility. Due to the continent's expanding population and the growing trend of women delaying conception, there are a significant number of IVF centres throughout Europe. Additionally, the likelihood of conceiving naturally declines with age, which raises the number of infertility issues. Consequently, a greater number of women are compelled to employ in vitro fertilisation banking services in order to increase the success rate, which is anticipated to spur market expansion. Furthermore, it is projected that the IVF industry will continue to expand because these centres work to remove the stigma attached to infertility by offering public support for all reproductive treatment options.
The expansion of the European IVF business is also being aided by rising awareness of the range of infertility treatment options available. Additionally, the market participants' increasing efforts to raise awareness of infertile centres and infertility treatment through social media and television aid in spreading knowledge about the cost and course of treatment, which encourages treatment adoption among those living in rural areas and those with low levels of education.
However, it is projected that stringent government controls and the high prices of IVF treatments will slow the growth pace of the regional industry. Furthermore, because IVF operations have a lower success rate, a patient can require many pregnancy cycles, which raises the overall cost. The typical cost of this operation is between USD 15,125 and USD 25,300, which is frequently a major deterrent to using the method. The absence of reimbursement and ethical issues are two other obstacles impeding the market's expansion. Furthermore, the absence of reimbursements and ethical objections to IVF impede the expansion of the European IVF business.
Market Competitive Landscape
The major key players in the Europe In-Vitro Fertilization (IVF) Market are: Cadila Healthcare Ltd., DRK Kliniken Berlin, EMD Serono Inc., LG Life Sciences, Sun Pharmaceutical Industries Ltd., Thermo Fisher Scientific, Inc., Others.
Scope of the Report:
| Report Metric | Details |
| Market size available for years | 2019-2033 |
| Base year considered | 2022 |
| Forecast period | 2023-2033 |
| Segments covered | By Cycle Type, By End User
|
| Regions covered | Denmark, France, Germany, Italy, Russia, Spain, UK, Rest of Europe
|
| Companies Covered | Cadila Healthcare Ltd., DRK Kliniken Berlin, EMD Serono Inc., LG Life Sciences, Sun Pharmaceutical Industries Ltd., Thermo Fisher Scientific, Inc., Others |
COVID-19 Impact on Europe In-Vitro Fertilization (IVF) Market
The epidemic caused problems in the Europe In-Vitro Fertilisation (IVF) sector. IVF treatments were impacted by travel restrictions, lockdowns, and priorities within the healthcare system. There were delays and cancellations as a result of the temporary suspension of non-essential medical services, such as reproductive treatments. Patients were hesitant to undergo reproductive therapy due to uncertainties. But when regulations relaxed, the market showed signs of recovery and a renewed emphasis on safety precautions. In the IVF sector, the pandemic highlighted the value of resilience and strategic planning.
Key Target Audience
- Fertility Clinics and Centers
- Pharmaceutical Companies
- Medical Device Manufacturers
- Hospitals and Clinics
- Research Institutions
- Others
Our in-depth analysis of the Europe In-Vitro Fertilization (IVF) Market includes the following segments:
|
By Cycle Type:
|
Donor Egg IVF Cycle
Fresh Cycle (Non-Donor)
Thawed IVF Cycle (Non-Donor)
|
|
By End User:
|
Clinical Research Institutes
Fertility Clinics
Hospitals
Surgical Centers
|
|
By Region:
|
Denmark
France
Germany
Italy
Russia
Spain
UK
Rest of Europe
|
Key Topics Covered in the Report
- Europe In-Vitro Fertilization (IVF) Market Size (FY’2023-FY’2033)
- Overview of Europe In-Vitro Fertilization (IVF) Market
- Segmentation of Europe In-Vitro Fertilization (IVF) Market By Cycle Type (Donor Egg IVF Cycle, Fresh Cycle, Thawed IVF Cycle)
- Segmentation of Europe In-Vitro Fertilization (IVF) Market By End User (Clinical Research Institutes, Fertility Clinics, Hospitals, Surgical Centers)
- Statistical Snap of Europe In-Vitro Fertilization (IVF) Market
- Expansion Analysis of Europe In-Vitro Fertilization (IVF) Market
- Problems and Obstacles in Europe In-Vitro Fertilization (IVF) Market
- Competitive Landscape in the Europe In-Vitro Fertilization (IVF) Market
- Impact of COVID-19 and Demonetization on Europe In-Vitro Fertilization (IVF) Market
- Details on Current Investment in Europe In-Vitro Fertilization (IVF) Market
- Competitive Analysis of Europe In-Vitro Fertilization (IVF) Market
- Prominent Players in the Europe In-Vitro Fertilization (IVF) Market
- SWOT Analysis of Europe In-Vitro Fertilization (IVF) Market
- Europe In-Vitro Fertilization (IVF) Market Future Outlook and Projections (FY’2023-FY’2033)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPER’s internal database
2.1.4. Premium insight from KOL’s
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
4.2. COVID-19 Impacts of the Europe In-Vitro Fertilization (IVF) Market
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTER’s Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Europe In-Vitro Fertilization (IVF) Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Europe In-Vitro Fertilization (IVF) Market
7. Europe In-Vitro Fertilization (IVF) Market, By Cycle Type (USD Million)
7.1. Europe In-Vitro Fertilization (IVF) Market Value Share and Forecast, By Cycle Type, 2023-2033
7.2. Donor Egg IVF Cycle
7.3. Fresh Cycle (Non-Donor)
7.4. Thawed IVF Cycle (Non-Donor)
8. Europe In-Vitro Fertilization (IVF) Market, By End User (USD Million)
8.1. Europe In-Vitro Fertilization (IVF) Market Value Share and Forecast, By End User, 2023-2033
8.2. Clinical Research Institutes
8.3. Fertility Clinics
8.4. Hospitals
8.5. Surgical Centers
9. Europe In-Vitro Fertilization (IVF) Market Forecast, 2019-2033 (USD Million)
9.1. Europe In-Vitro Fertilization (IVF) Market Size and Market Share
10. Europe In-Vitro Fertilization (IVF) Market, By Cycle Type, 2019-2033 (USD Million)
10.1. Europe In-Vitro Fertilization (IVF) Market Size and Market Share By Cycle Type (2019-2026)
10.2. Europe In-Vitro Fertilization (IVF) Market Size and Market Share By Cycle Type (2027-2033)
11. Europe In-Vitro Fertilization (IVF) Market, By End User, 2019-2033 (USD Million)
11.1. Europe In-Vitro Fertilization (IVF) Market Size and Market Share By End User (2019-2026)
11.2. Europe In-Vitro Fertilization (IVF) Market Size and Market Share By End User (2027-2033)
12. Europe In-Vitro Fertilization (IVF) Market, By Region, 2019-2033 (USD Million)
12.1. Europe In-Vitro Fertilization (IVF) Market Size and Market Share By Region (2019-2026)
12.2. Europe In-Vitro Fertilization (IVF) Market Size and Market Share By Region (2027-2033)
12.3. Denmark
12.4. France
12.5. Germany
12.6. Italy
12.7. Russia
12.8. Spain
12.9. UK
12.10. Rest of Europe
13. Company Profile
13.1. Limited Cadila Healthcare Ltd.
13.1.1. Company details
13.1.2. Financial outlook
13.1.3. Product summary
13.1.4. Recent developments
13.2. DRK Kliniken Berlin
13.2.1. Company details
13.2.2. Financial outlook
13.2.3. Product summary
13.2.4. Recent developments
13.3. EMD Serono Inc.
13.3.1. Company details
13.3.2. Financial outlook
13.3.3. Product summary
13.3.4. Recent developments
13.4. LG Life Sciences
13.4.1. Company details
13.4.2. Financial outlook
13.4.3. Product summary
13.4.4. Recent developments
13.5. Sun Pharmaceutical Industries Ltd.
13.5.1. Company details
13.5.2. Financial outlook
13.5.3. Product summary
13.5.4. Recent developments
13.6. Thermo Fisher Scientific, Inc.
13.6.1. Company details
13.6.2. Financial outlook
13.6.3. Product summary
13.6.4. Recent developments
13.7. Others
14. List of Abbreviations
15. Reference Links
16. Conclusion
17. Research Scope
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
